Cellular therapies Head of Stem Cell Transplantation: Prof. Dr. med. Matthias Eder Head of CAR T-cell program: PD Dr. med. Christian Schultze-Florey Head of the Tabelecleucel program: PD Dr. med. Chri

Multiple myeloma and plasma cell dyscrasias Management: PD Dr. Annamaria Brioli Multiple myeloma - MM - is a malignant blood cancer and the second most common hematologic disease. However, thanks to n

MPN focus center Management: Prof. Dr. med. Florian Heidel Myeloproliferative neoplasms Myeloproliferative neoplasms - MPNs - are a group of rare malignant blood cancers. Common forms of MPN include e

Acute myeloid leukemia / myelodysplastic syndromes Management: Prof. Dr. med. Felicitas Thol Acute leukemias are malignant blood cancers that affect blood formation particularly quickly and require tr

Specialists and assistant physicians in the Clinical Department

Our employees Would you like to become part of our team? Current vacancies All current vacancies in our Clinical Department can be found on the official MHH job portal! Unsolicited applications Of cou

Translational Epigenetics Emmy Noether Research Group Our group focuses on the functional characterization of epigenetic alterations that are required for the growth advantage of pre-malignant stem ce

Hristo Zlatev E-Mail: zlatev.hristo(at)mh-hannover.de

Pathogenetic Signalling Dr. Kira Behrens Our group investigates the cellular and molecular mechanisms driving the initiation and progression of myeloproliferative neoplasms (MPN), with a focus on how